Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Dermot Mark Durcan

At a glance: Dermot Mark Durcan is Director at Cencora (COR). Their latest SEC Form 4, filed Jun 22, 2026, reported a purchase of $1.1M. On file: 2 purchase lines ($2.2M) and 0 sale lines ($0).

Disclosed holdings: about $10.9M of COR stock: 31,767 shares reported on their latest Form 4 (filed Jun 22, 2026), valued at the Nov 20, 2026 close of $343.02. This counts only COR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Cencora, Inc. (COR)

Purchase track record

Strong record. Based on 2 purchases with a full 90 days of price history.

75
Avg. 90-day return+19.8%
vs. S&P 500+16.8%
Beat the market100%
Paper profit on buys+$582K
Total bought / sold$2.2M / $0

Dermot Mark Durcan's InsiderPrint

5 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of Dermot Mark Durcan: 5 trades, 2020 to 20262020: 2 buys, 0 sales2021: 0 buys, 0 sales2022: 0 buys, 0 sales2023: 0 buys, 0 sales2024: 1 buy, 0 sales2025: 0 buys, 0 sales2026: 2 buys, 0 sales

Reading this print: Almost only buys, trading about once a year, typically $109K a trade.

  • Bump outward: a purchase (5)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Jack BoyleDirector · WWW · 100% match
  2. John SchraudenbachDirector · PAL · 100% match
  3. William H. Adams IIIDirector · TXO · 100% match
  4. Robert A. McCabe Jr.Director · NHI · 99% match
  5. Brian HirschDirector · ACVA · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2024

From the SEC's insider data sets: each open-market buy by Dermot Mark Durcan, matched to how the stock did over the next 90 days against the S&P 500.

2 of 3 buys beat the S&P 500 (67%), median +5.0% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
CORJun 24, 2026+5.0%
CORMay 28, 2026+20.9%
CORMay 29, 2024-0.3%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Jun 22SEC CORCencora, Inc.First buy in 2 yrsPast buys 2/3 beat S&P Buy 4,00031,767 held (+14%) $274.19 $1.1M +25.1%
May 28SEC CORCencora, Inc.Past buys 2/3 beat S&P Buy 4,00027,767 held (+17%) $266.26 $1.1M +28.8%
  • Buy

    Director Dermot Mark Durcan bought $1.1M of COR at $266.26 — first open-market purchase in our records.

Follow Dermot Mark Durcan

Get one email when Dermot Mark Durcan files a new purchase or sale. Free.

At most one email a day about Dermot Mark Durcan, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.